Records 1-5 (of 5 Records) |
Query Trace: CSF3[original query]>>CSF3[Gene] |
---|
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection. Solimani Farzan, et al. European journal of immunology 2021 3 0. ![]() ![]() |
CSF3 Is a Potential Drug Target for the Treatment of COVID-19. Fang Chao, et al. Frontiers in physiology 2020 0 0. 605792 ![]() ![]() ![]() |
A comprehensive review of COVID-19 in India: A frequent catch of the information. Shivangi Shivangi, et al. Biotechnology and applied biochemistry 2021 1 0. ![]() ![]() ![]() |
Role of inflammatory markers in corona virus disease (COVID-19) patients: A review. Upadhyay Jyoti, et al. Experimental biology and medicine (Maywood, N.J.) 2020 0 0. (15) 1368-1375 ![]() ![]() |
Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Nunnari Giuseppe, et al. Experimental cell research 2020 7 0. (2) 112204 ![]() ![]() |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 05, 2023
- Content source: